A study to compare the effect of Shatapushpa oil enema and Metformin tablets on irregular or scanty periods and obesity in women with Polycystic Ovary Syndrome (PCOS).

Evaluation of comparative efficacy of Shatpushpa (Anethum sowa) tail (Oil) Matra Basti versus Tab Metformin in Artavkshaya (Oligomenorrhea/hypomenorrhea) and obesity with special reference to POLYCYSTIC OVARAIN SYNDROME (PCOS) -A randomised control trial. - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104441

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Female patients aged between 18 to 35 years. Diagnosed cases of Polycystic Ovarian Syndrome with oligomenorrhea or hypomenorrhea. Body Mass Index between 23 to 30 kg per square meter. Waist circumference more than 80 cm. Patients willing to participate and provide written informed consent

Exclusion criteria

Exclusion criteria: Body Mass Index less than 23 kg per square meter and more than 30 kg per square meter. Patients having any other disease causing oligomenorrhea and anovulation excluding Polycystic Ovarian Syndrome as per Rotterdam criteria. Known cases of Type 2 diabetes mellitus. Known cases of hyperandrogenemia such as congenital adrenal hyperplasia, androgen secreting neoplasms and Cushing syndrome. Known cases of thyroid disease or severe cardiovascular disease. Known cases of kidney or liver disease. History of hypersensitivity to Tab Metformin or Shatpushpa Anethum sowa. Pregnant women. Breastfeeding women. Known cases of hyperprolactinemia.

Design outcomes

Primary

Measure	Time frame
1.To evaluate the effect of Shatpushpa (Anethum sowa) tail (Oil) matrabasti in POLYCYSTIC OVARAIN SYNDROME (PCOS) induced Artavkshaya (oligomenorrhea or hypomenorrhoea) 2.To evaluate the effect of Shatpushpa (Anethum sowa) tail (Oil) matrabasti in POLYCYSTIC OVARAIN SYNDROME (PCOS) induced obesity. Timepoint: Every 15th days for 3 months	—

Secondary

Measure	Time frame
To evaluate the effect of Shatpushpa (Anethum sowa) tail (Oil) Matra Basti on clinical hyperandrogenism.Timepoint: Every 15th days for 3 months	—

Countries

India

Contacts

Public ContactDr Najmabanu Oubaidurrehman Siddique

Dr. Rajendra Gode Ayurved College Hospital and Research center Amravati

pudgal9@gmail.com9284295220

Outcome results